Cancer Antibody Drug Conjugates Market, Drugs Approval & Clinical Trials Report 2024 - A US$ 50 Billion+ Market Opportunity By 2030
October 31, 2024 12:57 ET
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
Global Cancer Antibody Drug Conjugates Market Size Forecast 2030
October 22, 2024 14:33 ET
|
KuicK Research
Delhi, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: Global...
SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight
September 19, 2024 07:34 ET
|
KuicK Research
Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
Cancer Antibody Drug Conjugates Market Size Clinical Trials Insight
August 23, 2023 02:53 ET
|
KuicK Research
Delhi, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029 Report Highlights: Global Antibody...
Global Oncology Antibody Drug Conjugates Market Size
April 28, 2022 09:15 ET
|
Global Market Estimates
Brooklyn, New York, April 28, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is...
Cancer Antibody Drug Conjugate Market 2028
February 24, 2022 02:57 ET
|
KuicK Research
Delhi, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028 Report Highlights: Global Cancer Antibody Drug...